RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity
Xiao Hu, Jacques Moisan, Kinga Majchrzak, Chuck Lesch, Yahong Wang, Brian Sanchez, Xikui Liu, Rodney Morgan, David Mertz, Dick Bousley, Chad van Huis, Don Skalitzky, Clarke Taylor, Thomas Aicher, Peter Toogood, Weiping Zou, Gary Glick, Chrystal Paulos, Laura Carter
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P23; DOI: 10.1186/2051-1426-3-S2-P23
